Gene · 55165
Papers1,450
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,450
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of key biomarkers and related immune cell infiltration in cervical cancer tissue based on bioinformatics analysis. | Sci Rep | 2023 | 37344577 | PubTator, text mining | PubMed |
| N-terminal proteoforms may engage in different protein complexes. | Life Sci Alliance | 2023 | 37316325 | PubTator, text mining | PubMed |
| Extracellular vesicles in oral squamous cell carcinoma: current progress and future prospect. | Front Bioeng Biotechnol | 2023 | 37304135 | PubTator, text mining | PubMed |
| Integrative bioinformatics and RNA sequencing based methodology results in the exploration of breast invasive carcinoma biomarkers. | Am J Transl Res | 2023 | 37303632 | PubTator, text mining | PubMed |
| Screening of four signature genes for clinical testing through bioinformatics and in vitro methods in head and neck squamous cell carcinoma. | Am J Cancer Res | 2023 | 37293145 | PubTator, text mining | PubMed |
| LIS1 RNA-binding orchestrates the mechanosensitive properties of embryonic stem cells in AGO2-dependent and independent ways. | Nat Commun | 2023 | 37280197 | PubTator, text mining | PubMed |
| CEP55 as a promising biomarker and therapeutic target on gallbladder cancer. | Front Oncol | 2023 | 37274251 | PubTator, text mining | PubMed |
| Value of non-coding RNAs to assess lymph node status in cervical cancer. | Front Oncol | 2023 | 37234986 | PubTator, text mining | PubMed |
| Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma. | BMC Med Genomics | 2023 | 37198621 | PubTator, text mining | PubMed |
| Identification of lncRNAs involved in response to ionizing radiation in fibroblasts of long-term survivors of childhood cancer and cancer-free controls. | Front Oncol | 2023 | 37182169 | PubTator, text mining | PubMed |
| A Comprehensive Pan-Cancer Analysis Identifies CEP55 as a Potential Oncogene and Novel Therapeutic Target. | Diagnostics (Basel) | 2023 | 37175004 | PubTator, text mining | PubMed |
| CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers. | BMC Pulm Med | 2023 | 37173675 | PubTator, text mining | PubMed |
| The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions. | Front Endocrinol (Lausanne) | 2023 | 37152960 | PubTator, text mining | PubMed |
| ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines. | Cell | 2023 | 37146611 | PubTator, text mining | PubMed |
| A novel signature based on cancer-associated fibroblast genes to predict prognosis, immune feature, and therapeutic response in breast cancer. | Aging (Albany NY) | 2023 | 37142271 | PubTator, text mining | PubMed |
| The multifaceted interactions between pathogens and host ESCRT machinery. | PLoS Pathog | 2023 | 37141275 | PubTator, text mining | PubMed |
| Establishment of a 7-gene prognostic signature based on oxidative stress genes for predicting chemotherapy resistance in pancreatic cancer. | Front Pharmacol | 2023 | 37138854 | PubTator, text mining | PubMed |
| Circ_0001387 regulates SKA2 to accelerate breast cancer progression through miR-136-5p. | Thorac Cancer | 2023 | 37132052 | PubTator, text mining | PubMed |
| Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy. | Biology (Basel) | 2023 | 37106813 | PubTator, text mining | PubMed |
| Large-scale phage-based screening reveals extensive pan-viral mimicry of host short linear motifs. | Nat Commun | 2023 | 37100772 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55165/papers?page=10